AAREYDRUGSPharmaceuticals
Aarey Drugs & Pharmaceuticals Ltd — Balance Sheet
₹50.75
-9.78%
Aarey Drugs & Pharmaceuticals Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 2.80 Cr | 2.81 Cr | 2.54 Cr | 2.54 Cr | — |
| Share Issued | 2.80 Cr | 2.81 Cr | 2.54 Cr | 2.54 Cr | — |
| Net Debt | 33.38 Cr | 29.76 Cr | 37.01 Cr | 13.97 Cr | — |
| Total Debt | 34.86 Cr | 31.35 Cr | 37.72 Cr | 14.16 Cr | — |
| Tangible Book Value | 138.48 Cr | 132.76 Cr | 117.41 Cr | 113.64 Cr | — |
| Invested Capital | 173.34 Cr | 164.11 Cr | 155.13 Cr | 127.80 Cr | — |
| Working Capital | 116.40 Cr | 116.04 Cr | 102.47 Cr | 92.08 Cr | — |
| Net Tangible Assets | 138.48 Cr | 132.76 Cr | 117.41 Cr | 113.64 Cr | — |
| Common Stock Equity | 138.48 Cr | 132.76 Cr | 117.41 Cr | 113.64 Cr | — |
| Total Capitalization | 140.47 Cr | 135.98 Cr | 121.77 Cr | 116.98 Cr | — |
| Total Equity Gross Minority Interest | 138.48 Cr | 132.76 Cr | 117.41 Cr | 113.64 Cr | — |
| Stockholders Equity | 138.48 Cr | 132.76 Cr | 117.41 Cr | 113.64 Cr | — |
| Other Equity Interest | 110.43 Cr | 2.46 Cr | 2.31 Cr | 2.31 Cr | — |
| Capital Stock | 28.05 Cr | 28.05 Cr | 25.38 Cr | 25.38 Cr | — |
| Common Stock | 28.05 Cr | 28.05 Cr | 25.38 Cr | 25.38 Cr | — |
| Total Liabilities Net Minority Interest | 99.79 Cr | 170.54 Cr | 173.92 Cr | 131.53 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 2.91 Cr | 3.99 Cr | 5.78 Cr | 4.80 Cr | — |
| Other Non Current Liabilities | -1000.00 | 0.02 Cr | -1000.00 | -1000.00 | — |
| Non Current Deferred Taxes Liabilities | 0.92 Cr | 0.75 Cr | 1.42 Cr | 1.46 Cr | — |
| Long Term Debt And Capital Lease Obligation | 1.99 Cr | 3.22 Cr | 4.36 Cr | 3.34 Cr | — |
| Long Term Debt | 1.99 Cr | 3.22 Cr | 4.36 Cr | 3.34 Cr | — |
| Current Liabilities | 96.88 Cr | 166.55 Cr | 168.14 Cr | 126.74 Cr | — |
| Other Current Liabilities | 5.73 Cr | 5.41 Cr | 2.17 Cr | 1.02 Cr | — |
| Current Debt And Capital Lease Obligation | 32.87 Cr | 28.13 Cr | 33.36 Cr | 10.82 Cr | — |
| Current Debt | 32.87 Cr | 28.13 Cr | 33.36 Cr | 10.82 Cr | — |
| Current Provisions | 2.73 Cr | 0.22 Cr | 0.22 Cr | 2.62 Cr | — |
| Payables | 55.55 Cr | 129.29 Cr | 127.34 Cr | 112.41 Cr | — |
| Total Tax Payable | 1.40 Cr | 0.29 Cr | 0.56 Cr | 2.74 Cr | — |
| Accounts Payable | 54.15 Cr | 128.94 Cr | 127.33 Cr | 109.66 Cr | — |
| Total Assets | 238.27 Cr | 303.29 Cr | 291.32 Cr | 245.17 Cr | — |
| Total Non Current Assets | 24.98 Cr | 20.71 Cr | 20.72 Cr | 26.35 Cr | — |
| Investmentin Financial Assets | 7.79 Cr | 1.39 Cr | 0.41 Cr | 2.80 Cr | — |
| Available For Sale Securities | 7.79 Cr | 1.39 Cr | 0.41 Cr | 2.80 Cr | — |
| Net PPE | 16.22 Cr | 12.96 Cr | 13.94 Cr | 14.47 Cr | — |
| Current Assets | 213.28 Cr | 282.59 Cr | 270.61 Cr | 218.82 Cr | — |
| Other Current Assets | 5.03 Cr | 0.06 Cr | 0.06 Cr | 1.46 Cr | — |
| Inventory | 45.48 Cr | 34.68 Cr | 28.82 Cr | 13.68 Cr | — |
| Other Receivables | 29.94 Cr | 15.51 Cr | 9.01 Cr | 0.02 Cr | — |
| Accounts Receivable | 129.61 Cr | 184.48 Cr | 189.78 Cr | 136.28 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 3.23 Cr | 2.89 Cr | 1.12 Cr | 0.19 Cr | — |
| Other Short Term Investments | 1.76 Cr | 1.30 Cr | 0.42 Cr | 7.51 Cr | — |
| Cash And Cash Equivalents | 1.47 Cr | 1.59 Cr | 0.71 Cr | 0.19 Cr | — |
| Retained Earnings | — | 53.11 Cr | 48.42 Cr | 44.65 Cr | 38.11 Cr |
| Additional Paid In Capital | — | 48.93 Cr | 41.08 Cr | 41.08 Cr | 34.85 Cr |
| Current Deferred Taxes Liabilities | — | 3.85 Cr | 5.06 Cr | 2.62 Cr | 0.00 |
| Other Payable | — | 0.05 Cr | 0.01 Cr | — | — |
| Dividends Payable | — | 47000.00 | 47000.00 | 47000.00 | 47847.00 |
| Non Current Prepaid Assets | — | 5.65 Cr | 5.60 Cr | 5.11 Cr | — |
| Accumulated Depreciation | — | -20.92 Cr | -19.23 Cr | -17.65 Cr | -15.67 Cr |
| Gross PPE | — | 33.88 Cr | 33.16 Cr | 32.12 Cr | 29.93 Cr |
| Other Properties | — | 0.20 Cr | 0.20 Cr | 0.18 Cr | 0.14 Cr |
| Machinery Furniture Equipment | — | 29.39 Cr | 28.68 Cr | 27.66 Cr | 25.66 Cr |
| Buildings And Improvements | — | 3.91 Cr | 3.91 Cr | 3.90 Cr | 3.90 Cr |
| Land And Improvements | — | 0.38 Cr | 0.38 Cr | 0.38 Cr | 0.22 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 40.06 Cr | 38.82 Cr | 66.10 Cr | 37.20 Cr |
| Finished Goods | — | 23.17 Cr | 19.97 Cr | 8.51 Cr | 13.90 Cr |
| Work In Process | — | 0.81 Cr | 1.75 Cr | 0.26 Cr | 0.53 Cr |
| Raw Materials | — | 10.70 Cr | 7.10 Cr | 4.92 Cr | 4.02 Cr |
| Taxes Receivable | — | 4.90 Cr | 2.98 Cr | 1.08 Cr | 0.00 |
| Cash Financial | — | 1.59 Cr | 0.71 Cr | 0.19 Cr | 0.65 Cr |
| Restricted Cash | — | — | — | 2.40 Cr | 84343.00 |
| Non Current Deferred Taxes Assets | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Aarey Drugs & Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.